Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents

被引:29
作者
Mukherjee, R
Jaggi, M
Rajendran, P
Srivastava, SK
Siddiqui, MJA
Vardhan, A
Burman, AC
机构
[1] Dabur Res Fdn, Div Expt Oncol, Ghaziabad 201010, Uttar Pradesh, India
[2] Dabur Res Fdn, Div Med Chem, Ghaziabad 201010, Uttar Pradesh, India
[3] Dabur Res Fdn, Div Chem Res, Ghaziabad 201010, Uttar Pradesh, India
关键词
D O I
10.1016/j.bmcl.2004.04.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New 3-O-acyl, 3-benzylidene, 3-hydrazone, 3-hydrazine, 17-carboxyacryloyl ester derivatives of betulinic acid (2-6, 8-11, 13, 17, 18, 21, and 22) were synthesized and evaluated in vitro for anti-angiogenic activity on endothelial cell cytotoxicity, specificity, and tube-formation ability. All derivatives reported here showed IC50 < 4 mug/mL. Compounds 3, 9, 10, 17, 21, and 22 have shown better cytotoxicity (IC50 < 1.2 mug/mL) than betulinic acid (1) and improved endothelial cell specificity (ECS > 10) in some cases. Compounds 10, 17, and 18 have shown 20%, 32%, and 48% reduction in TLS, respectively, and were found better than betulinic acid (1). We have shown that 20,29-dihydrobetulinic acid derivatives have better anti-angiogenic activity as compared to betulinic acid or its other derivatives. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3169 / 3172
页数:4
相关论文
共 13 条
[1]   Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection [J].
Cichewicz, RH ;
Kouzi, SA .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :90-114
[2]  
HO JK, 2002, JPN J CANCER RES, V93, P417
[3]  
Jaggi M., 2002, U.S. Patent, Patent No. [6,403,816 B1, 6403816, 6,403,816B1]
[4]  
Jaggi M., 2001, US Patent, Patent No. [6228850 B1, 6228850]
[5]   Betulinic acid inhibits aminopeptidase N activity [J].
Melzig, MF ;
Bormann, H .
PLANTA MEDICA, 1998, 64 (07) :655-657
[7]   Betulinic acid and its derivatives as anti-angiogenic agents [J].
Mukherjee, R ;
Jaggi, M ;
Rajendran, P ;
Siddiqui, MJA ;
Srivastava, SK ;
Vardhan, A ;
Burman, AC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2181-2184
[8]   DISCOVERY OF BETULINIC ACID AS A SELECTIVE INHIBITOR OF HUMAN-MELANOMA THAT FUNCTIONS BY INDUCTION OF APOPTOSIS [J].
PISHA, E ;
CHAI, H ;
LEE, IS ;
CHAGWEDERA, TE ;
FARNSWORTH, NR ;
CORDELL, GA ;
BEECHER, CWW ;
FONG, HHS ;
KINGHORN, AD ;
BROWN, DM ;
WANI, MC ;
WALL, ME ;
HIEKEN, TJ ;
DASGUPTA, TK ;
PEZZUTO, JM .
NATURE MEDICINE, 1995, 1 (10) :1046-1051
[9]  
RAMADOSS S, 2003, Patent No. 6670345
[10]  
Ramadoss S., 2000, Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this, Patent No. [US6048847, 6048847]